INTERLEUKIN-7 IS A GROWTH-FACTOR FOR SEZARY LYMPHOMA-CELLS

被引:137
作者
DALLOUL, A
LAROCHE, L
BAGOT, M
MOSSALAYI, MD
FOURCADE, C
THACKER, DJ
HOGGE, DE
MERLEBERAL, H
DEBRE, P
SCHMITT, C
机构
[1] CHU PITIE SALPETRIERE,IMMUNOL LAB,IMMUNOHEMATOL MOLEC GRP,CNRS,URA 625,91 BD HOP,PORTE 510,F-75013 PARIS,FRANCE
[2] BRITISH COLUMBIA CANC AGCY,TERRY FOX LAB,VANCOUVER V5Z IL3,BC,CANADA
[3] HOP HENRI MONDOR,SERV DERMATOL,F-94010 CRETEIL,FRANCE
[4] HOP AVICENNE,UNITE DERMATOL,F-93009 BOBIGNY,FRANCE
关键词
CYTOKINES; CUTANEOUS T-CELL LYMPHOMA; PROLIFERATION; CELL LINES; SURFACE MARKERS;
D O I
10.1172/JCI115920
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Sezary syndrome is a cutaneous T cell lymphoma characterized by infiltration of the skin by CD4+ cells. These cells generally respond poorly to mitogens and T cell activators. We have studied the action of IL1 to IL4, IL6, and IL7 on the proliferation of Sezary cells from 12 patients. With the exception of IL2 and IL7, the cytokines studied had no proliferative effect on these cells. Whereas IL2 had only a low proliferative capacity (two-to threefold increase) on peripheral blood mononuclear cells, recombinant IL7 constantly induced a very significant (3-40-fold increase) proliferative response, and was used successfully to generate cell lines in three out of eight cases. Growth of Sezary cell lines was shown to be strictly dependent on IL7, and after 2-5 wk of culture presented a switch to a homogeneous phenotype CD3+4+8-7- (except for one line that remained CD7+), with a typical morphology of Sezary cells. Their tumoral origin was demonstrated by the expression of the same T cell receptor-beta gene rearrangement as the patients' T cells. Importantly, cultured normal epidermal keratinocyte supernatants could support the growth of our Sezary lines. Furthermore, the proliferative activity contained in these supernatants was completely blocked by a monoclonal anti-IL7 antibody. These results suggest that IL7 may, therefore, represent an important cytokine in the physiopathology of cutaneous T cell lymphoma.
引用
收藏
页码:1054 / 1060
页数:7
相关论文
共 36 条
[1]  
ABRAMS JT, 1991, J IMMUNOL, V146, P1455
[2]  
ANDERSON MR, 1990, J EXP MED, V172, P577
[3]  
BOUMSELL L, 1981, BLOOD, V57, P526
[4]   SEZARY SYNDROME - MALIGNANT PROLIFERATION OF HELPER T CELLS [J].
BRODER, S ;
EDELSON, RL ;
LUTZNER, MA ;
NELSON, DL ;
MACDERMOTT, RP ;
DURM, ME ;
GOLDMAN, CK ;
MEADE, BD ;
WALDMANN, TA .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (06) :1297-1306
[5]   INDICATIONS OF THYMUS-DERIVED NATURE OF PROLIFERATING CELLS IN 6 PATIENTS WITH SEZARYS SYNDROME [J].
BROUET, JC ;
FLANDRIN, G ;
SELIGMANN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (07) :341-344
[6]  
BUNN PA, 1981, BLOOD, V57, P452
[7]  
CAPESIUS C, 1991, LEUKEMIA, V5, P416
[8]   LYMPHOCYTE-TRANSFORMATION IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMAS [J].
CARNEY, DN ;
BUNN, PA ;
SCHECHTER, GP ;
GAZDAR, AF .
INTERNATIONAL JOURNAL OF CANCER, 1980, 26 (05) :535-542
[9]  
COLON PJ, 1989, BLOOD, V74, P1368
[10]  
DALLOUL AH, 1991, BLOOD, V77, P69